Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Hernandez

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery and structure-activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agentsTsutomu Akama, Chen Dong, Charlotte Virtucio, et al.
Science (New York, N.Y.)|June 26, 2007
An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing siteFernando L Rock, Weimin Mao, Anya Yaremchuk, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of novel benzoxaborole-based potent antitrypanosomal agentsDazhong Ding, Yaxue Zhao, Qingqing Meng, et al.
Cell|January 23, 2026
Cell-type resolved protein atlas of brain lysosomes identifies SLC45A1-associated disease as a lysosomal disorderAli Ghoochani, Julia C Heiby, Eshaan S Rawat, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse ModelGregory T Robertson, Victoria A Ektnitphong, Michael S Scherman, et al.
Journal of Medicinal Chemistry|September 28, 2017
Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)Xianfeng Li, Vincent Hernandez, Fernando L Rock, et al.
Life Science Alliance|November 21, 2018
Discovery of a cofactor-independent inhibitor of <i>Mycobacterium tuberculosis</i> InhAYi Xia, Yasheen Zhou, David S Carter, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteriaVincent Hernandez, Thibaut Crépin, Andrés Palencia, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseAndrés Palencia, Xianfeng Li, Wei Bu, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters|October 1, 2013
Discovery and structure-activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agentsTsutomu Akama, Chen Dong, Charlotte Virtucio, et al.
Science (New York, N.Y.)|June 26, 2007
An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing siteFernando L Rock, Weimin Mao, Anya Yaremchuk, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of novel benzoxaborole-based potent antitrypanosomal agentsDazhong Ding, Yaxue Zhao, Qingqing Meng, et al.
Cell|January 23, 2026
Cell-type resolved protein atlas of brain lysosomes identifies SLC45A1-associated disease as a lysosomal disorderAli Ghoochani, Julia C Heiby, Eshaan S Rawat, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse ModelGregory T Robertson, Victoria A Ektnitphong, Michael S Scherman, et al.
Journal of Medicinal Chemistry|September 28, 2017
Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)Xianfeng Li, Vincent Hernandez, Fernando L Rock, et al.
Life Science Alliance|November 21, 2018
Discovery of a cofactor-independent inhibitor of <i>Mycobacterium tuberculosis</i> InhAYi Xia, Yasheen Zhou, David S Carter, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteriaVincent Hernandez, Thibaut Crépin, Andrés Palencia, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA SynthetaseAndrés Palencia, Xianfeng Li, Wei Bu, et al.
Pageof 3